The Amiloride-Sensitive Endothelial Sodium Channel and Vascular Tone

被引：20

作者：

Warnock, David G. ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA

来源：

HYPERTENSION | 2013年 / 61卷 / 05期

关键词：

CYSTIC-FIBROSIS; ALDOSTERONE; DESIGN; ENAC;

D O I：

10.1161/HYPERTENSIONAHA.113.00768

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：952 / 954

页数：3

共 20 条

[1]

[Anonymous], COCHRANE DATABASE SY

[2] EPITHELIAL SODIUM-CHANNEL RELATED TO PROTEINS INVOLVED IN NEURODEGENERATION [J].

CANESSA, CM ;

HORISBERGER, JD ;

ROSSIER, BC .

NATURE, 1993, 361 (6411) :467-470

[3] The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure [J].

Cat, Aurelie Nguyen Dinh ;

Griol-Charhbili, Violaine ;

Loufrani, Laurent ;

Labat, Carlos ;

Benjamin, Laura ;

Farman, Nicolette ;

Lacolley, Patrick ;

Henrion, Daniel ;

Jaisser, Frederic .

FASEB JOURNAL, 2010, 24 (07) :2454-2463

[4] Menage a trois: Aldosterone, sodium and nitric oxide in vascular endothelium [J].

Fels, Johannes ;

Oberleithner, Hans ;

Kusche-Vihrog, Kristina .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (12) :1193-1202

[5] SIMPLE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE MEASUREMENT OF AMILORIDE IN BODY-FLUIDS [J].

FORREST, G ;

MCINNES, GT ;

FAIRHEAD, AP ;

THOMPSON, GG ;

BRODIE, MJ .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 428 (01) :123-130

[6]

HALL JE, 1986, FED PROC, V45, P2897

[7] Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease [J].

Hirsh, Andrew J. ;

Zhang, Jim ;

Zamurs, Andra ;

Fleegle, Jacquelyn ;

Thelin, William R. ;

Caldwell, Ray A. ;

Sabater, Juan R. ;

Abraham, William M. ;

Donowitz, Mark ;

Cha, Boyoung ;

Johnson, Kevin B. ;

St George, Judith A. ;

Johnson, M. Ross ;

Boucher, Richard C. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (01) :77-88

[8] Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: Drugs for cystic fibrosis and chronic bronchitis [J].

Hirsh, Andrew J. ;

Molino, Bruce F. ;

Zhang, Jianzhong ;

Astakhova, Nadezhda ;

Geiss, William B. ;

Sargent, Bruce J. ;

Swenson, Brian D. ;

Usyatinsky, Alexander ;

Wyle, Michael J. ;

Boucher, Richard C. ;

Smith, Rick T. ;

Zamurs, Andra ;

Johnson, M. Ross .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) :4098-4115

[9] Epithelial Sodium Channel Stiffens the Vascular Endothelium In Vitro and in Liddle Mice [J].

Jeggle, Pia ;

Callies, Chiara ;

Tarjus, Antoine ;

Fassot, Celine ;

Fels, Johannes ;

Oberleithner, Hans ;

Jaisser, Frederic ;

Kusche-Vihrog, Kristina .

HYPERTENSION, 2013, 61 (05) :1053-+

[10] δ ENaC: a novel divergent amiloride-inhibitable sodium channel [J].

Ji, Hong-Long ;

Zhao, Run-Zhen ;

Chen, Zai-Xing ;

Shetty, Sreerama ;

Idell, Steven ;

Matalon, Sadis .

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2012, 303 (12) :L1013-L1026

← 1 2 →